As we head into what many expect to be a pivotal year, we asked people from across the psychedelics field what they are excited about, concerned by, and hoping to gain clarity on in 2026. What emerges is a picture of tempered anticipation: acceptance of the importance of the year ahead is paired with a sober realism about what pivotal data, regulatory decisions, and access pathways may or may not resolve…
This recording is exclusively for our Pα+ subscribers.
Sign-in or join Pα+ to watch this video…
Join Pα+ Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.
Already a member? Log In
✓ Regular Bulletins covering key topics and trends in the psychedelics space
✓ Regular articles and deep dives across psychedelic research, policy and business
✓ Interviews with insiders
✓ Monthly interactive database and commentary on psychedelic patents
✓ Quick-take analysis of major developments
✓ A Library of primers and explainers
✓ Access to our full back catalogue
